Non-Communicable Diseases (NCDs) such as hypertension, diabetes, and high cholesterol are increasingly becoming a threat to public health in Indonesia. These three silent killers often show no symptoms, yet have serious impacts on quality of life and healthcare costs. Responding to this challenge, PT Dexa Medica, through its Cek Segitiga initiative, once again provided free health checks for the public, this time at Bintaro Xchange Mall, South Tangerang, on Saturday, September 27, 2025.

The event drew strong public enthusiasm, with more than 1,500 participants undergoing health checks that included blood pressure, blood sugar, and cholesterol tests. This program is part of Dexa Medica’s commitment to supporting the government’s initiative in early detection and prevention of NCDs.

“We organize Free Health Check activities as part of Dexa Medica’s commitment to supporting government programs,” explained Dexa Medica’s Commercial Director, Mr. Marimin.

He added that the main objective of this initiative is to improve public health through preventive efforts. “People are encouraged to undergo regular health checks, and this begins with the courage to come forward and get examined,” he said.
Mr. Marimin also emphasized Dexa Medica’s readiness to support the community’s medical needs. “Dexa Medica is highly committed—if there are future treatment needs related to infections or metabolic conditions, OGB Dexa medicines are available,” he noted.

Findings in the Field
Since it was launched in 2024, the Cek Segitiga program has reached 14 locations in 9 major cities, including Jakarta, Bogor, Bandung, Surabaya, Yogyakarta, Solo, Karawang, Palembang, and South Tangerang.
By September 2025, more than 10,750 people had benefited from this service. Previous health screenings revealed alarming findings:

  • 32.3% of participants were detected with hypertension,
  • 28% had high cholesterol,
  • 5.7% showed above-normal blood sugar levels.

The majority of participants came from the 20–40 year age group.
According to Dr. Angelina Wijaya, a General Practitioner at RS Premier Bintaro, the initiative had a tangible impact on public health awareness. She noted that free health checks play an important role in screening and preventing chronic disease trends.
“The most common cases are hypertension and high cholesterol. Since these conditions often present no symptoms yet can suddenly escalate, screening and maintaining a healthy lifestyle are crucial. That’s why it is important for the public to participate and make use of this opportunity,” she explained.
The program aligns not only with public health goals but also with Dexa Group’s core values.
Dexa Group’s Corporate HR & GA Director, Mr. Andy Samual, stressed that caring for health is part of the company’s values. “Cek Segitiga reflects Dexa Group’s concern, not only for the general public but also for our employees. This care is embedded in our core value: Deal with Care,” he stated.
The integration of medical screenings with community activities made the event more inclusive and engaging. This approach ensured that people were not only informed about their health risks but also motivated to take concrete steps toward a healthier lifestyle.

All Dexa Group Products Halal-Certified
As part of the event, Mr. Marimin also reaffirmed Dexa Group’s commitment to product quality and adherence to halal standards. The company ensures not only the quality of its products but also equitable access to medicine. “One more thing, as Indonesia is a Muslim-majority country, our halal-certified medicines can serve as a reliable choice for the community,” he highlighted.
The Cek Segitiga initiative also reflects the company’s philosophy: Expertise for the Promotion of Health. This philosophy is brought to life through tangible actions to support the government in reducing NCD prevalence while building public health awareness.
Dexa Medica underscored that this program is not the end, but rather the beginning of a long-term effort to achieve a healthier Indonesia. “Dexa Medica will continue to uphold its commitment to quality while ensuring that our medicines reach communities across the nation,” concluded Mr. Marimin.